Advertisement

Tumor Biology

, Volume 35, Issue 1, pp 573–579 | Cite as

Association of the interleukin-4Rα rs1801275 and rs1805015 polymorphisms with glioma risk

  • Jun Guo
  • Lei Shi
  • Min Li
  • Jin Xu
  • Shushan Yan
  • Chuang ZhangEmail author
  • Guan SunEmail author
Research Article

Abstract

Potential single-nucleotide polymorphisms (SNPs) of interleukin-4 receptor alpha (IL-4Rα) rs1801275 and rs1805015 have been implicated in glioma risk; however, the findings of previous published case–control studies are conflicting and inconclusive. We performed the updated meta-analysis with the aim to provide a more precise estimate for the role of interleukin-4Rα SNPs in glioma risk. The pooled odds ratios (ORs) with 95 % confidence intervals (CIs) were used to evaluate the strength of the gene association. Overall, the pooled analysis showed that the IL-4Rα rs1801275 polymorphism was associated with a decreased risk of glioma in the comparison of G vs. A (OR = 0.87, 95 % CI = 0.76–0.99, P OR = 0.041). Subgroup analysis by ethnicity revealed that the IL-4Rα rs1801275 variant G and GG + AG exerted a decreased risk effect on the development of glioma among Asians, but not Caucasians (G vs. A, OR = 0.81, 95 % CI = 0.69–0.95, P OR = 0.011; GG + AG vs. AA, OR = 0.80, 95 % CI = 0.66–0.96, P OR = 0.018). However, the IL-4Rα rs1805015 polymorphism did not modify the risk of glioma. Sensitivity analysis confirmed the reliability for all of the results. Our meta-analysis suggests that the polymorphism of IL-4Rα rs1801275 but not IL-4Rα rs1805015 plays a protective role in the glioma pathogenesis, particularly among Asians.

Keywords

Interleukin-4Rα Glioma Single-nucleotide polymorphism Meta-analysis 

Notes

Conflicts of interest

None.

References

  1. 1.
    Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol. 2006;2:494–503. Quiz 1 p following 16.PubMedCrossRefGoogle Scholar
  2. 2.
    Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005;109:93–108.PubMedCrossRefGoogle Scholar
  3. 3.
    Ohgaki H. Epidemiology of brain tumors. Methods Mol Biol. 2009;472:323–42.PubMedCrossRefGoogle Scholar
  4. 4.
    Wigertz A, Lonn S, Schwartzbaum J, Hall P, Auvinen A, Christensen HC, et al. Allergic conditions and brain tumor risk. Am J Epidemiol. 2007;166:941–50.PubMedCrossRefGoogle Scholar
  5. 5.
    Schoemaker MJ, Swerdlow AJ, Hepworth SJ, van Tongeren M, Muir KR, McKinney PA. History of allergic disease and risk of meningioma. Am J Epidemiol. 2007;165:477–85.PubMedCrossRefGoogle Scholar
  6. 6.
    Berg-Beckhoff G, Schuz J, Blettner M, Munster E, Schlaefer K, Wahrendorf J, et al. History of allergic disease and epilepsy and risk of glioma and meningioma (INTERPHONE study group, Germany). Eur J Epidemiol. 2009;24:433–40.PubMedCrossRefGoogle Scholar
  7. 7.
    Amirian E, Liu Y, Scheurer ME, El-Zein R, Gilbert MR, Bondy ML. Genetic variants in inflammation pathway genes and asthma in glioma susceptibility. Neuro Oncol. 2010;12:444–52.PubMedCentralPubMedGoogle Scholar
  8. 8.
    Jin T, Li X, Zhang J, Wang H, Geng T, Li G, et al. Genetic association between selected cytokine genes and glioblastoma in the Han Chinese population. BMC Cancer. 2013;13:236.PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Llanes E, Quiralte J, Lopez E, Sastre B, Chacartegui M, del Pozo V, et al. Analysis of polymorphisms in olive pollen allergy: IL13, IL4RA, IL5 and ADRB2 genes. Int Arch Allergy Immunol. 2009;148:228–38.PubMedCrossRefGoogle Scholar
  10. 10.
    Howard TD, Koppelman GH, Xu J, Zheng SL, Postma DS, Meyers DA, et al. Gene–gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J Hum Genet. 2002;70:230–6.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Liu X, Beaty TH, Deindl P, Huang SK, Lau S, Sommerfeld C, et al. Associations between specific serum IgE response and 6 variants within the genes IL4, IL13, and IL4RA in German children: the German Multicenter Atopy Study. J Allergy Clin Immunol. 2004;113:489–95.PubMedCrossRefGoogle Scholar
  12. 12.
    Cochran WG. The comparison of percentages in matched samples. Biometrika. 1950;37:256–66.PubMedGoogle Scholar
  13. 13.
    Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.PubMedCrossRefGoogle Scholar
  14. 14.
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMedGoogle Scholar
  15. 15.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRefGoogle Scholar
  16. 16.
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCrossRefGoogle Scholar
  17. 17.
    Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316:469. Author reply 70–1.PubMedCrossRefGoogle Scholar
  18. 18.
    Wiemels JL, Wiencke JK, Kelsey KT, Moghadassi M, Rice T, Urayama KY, et al. Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev. 2007;16:1229–35.PubMedCrossRefGoogle Scholar
  19. 19.
    Schwartzbaum JA, Ahlbom A, Lonn S, Malmer B, Wigertz A, Auvinen A, et al. An international case–control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk. Cancer Epidemiol Biomarkers Prev. 2007;16:2448–54.PubMedCrossRefGoogle Scholar
  20. 20.
    Ruan Z, Zhao Y, Yan L, Chen H, Fan W, Chen J, et al. Single nucleotide polymorphisms in IL-4Ra, IL-13 and STAT6 genes occurs in brain glioma. Front Biosci (Elite Ed). 2011;3:33–45.CrossRefGoogle Scholar
  21. 21.
    Li S, Jin T, Zhang J, Lou H, Yang B, Li Y, et al. Polymorphisms of TREH, IL4R and CCDC26 genes associated with risk of glioma. Cancer Epidemiol. 2012;36:283–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Chomarat P, Banchereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol. 1998;17:1–52.PubMedCrossRefGoogle Scholar
  23. 23.
    Heller NM, Gwinn WM, Donnelly RP, Constant SL, Keegan AD. IL-4 engagement of the type I IL-4 receptor complex enhances mouse eosinophil migration to eotaxin-1 in vitro. PLoS One. 2012;7:e39673.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Andrews AL, Holloway JW, Holgate ST, Davies DE. IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets. J Immunol. 2006;176:7456–61.PubMedGoogle Scholar
  25. 25.
    Hosoyama T, Aslam MI, Abraham J, Prajapati SI, Nishijo K, Michalek JE, et al. IL-4R drives dedifferentiation, mitogenesis, and metastasis in rhabdomyosarcoma. Clin Cancer Res. 2011;17:2757–66.PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Johnson LG, Schwartz SM, Malkki M, Du Q, Petersdorf EW, Galloway DA, et al. Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster. Cancer Epidemiol Biomarkers Prev. 2011;20:199–207.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Turner MC. Epidemiology: allergy history, IgE, and cancer. Cancer Immunol Immunother. 2012;61:1493–510.PubMedCrossRefGoogle Scholar
  28. 28.
    Olson SH, Orlow I, Simon J, Tommasi D, Roy P, Bayuga S, et al. Allergies, variants in IL-4 and IL-4R alpha genes, and risk of pancreatic cancer. Cancer Detect Prev. 2007;31:345–51.PubMedCrossRefGoogle Scholar
  29. 29.
    Curran CS, Bertics PJ. Eosinophils in glioblastoma biology. J Neuroinflammation. 2012;9:11.PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Backes DM, Siddiq A, Cox DG, Calboli FC, Gaziano JM, Ma J, et al. Single-nucleotide polymorphisms of allergy-related genes and risk of adult glioma. J Neurooncol. 2013;113:229–38.PubMedCrossRefGoogle Scholar
  31. 31.
    Schwartzbaum J, Ding B, Johannesen TB, Osnes LT, Karavodin L, Ahlbom A, et al. Association between prediagnostic IgE levels and risk of glioma. J Natl Cancer Inst. 2012;104:1251–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Calboli FC, Cox DG, Buring JE, Gaziano JM, Ma J, Stampfer M, et al. Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies. J Natl Cancer Inst. 2011;103:1588–95.PubMedCrossRefGoogle Scholar
  33. 33.
    Sun G, Wang X, Shi L, Yue X, Fu L, Chen C, et al. Association between polymorphisms in interleukin-4Ralpha and interleukin-13 and glioma risk: a meta-analysis. Cancer Epidemiol. 2013;37:306–10.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  1. 1.Department of NeurosurgeryFourth Affiliated Hospital of Nantong University, First Hospital of YanchengYanchengPeople’s Republic of China
  2. 2.Department of NeurosurgeryThe First People’s Hospital of Kunshan Affiliated with Jiangsu UniversitySuzhouPeople’s Republic of China
  3. 3.Department of NeurosurgeryJiangning Hospital Affiliated with Nanjing Medical UniversityNanjingPeople’s Republic of China
  4. 4.Department of Surgical OncologyThe Eighty-First Hospital of People’s Liberation ArmyNanjingPeople’s Republic of China
  5. 5.Department of Medical OncologyThe Eighty-First Hospital of People’s Liberation ArmyNanjingPeople’s Republic of China

Personalised recommendations